Skip to content

Diagnostic Importance of the Circulating Human Leucine-rich α-2-glycoprotein in Acute Appendicitis in Pediatric Patients

Diagnostic Importance of the Circulating Human Leucine-rich α-2-glycoprotein Analysed From Blood and Saliva in Children With Acute Appendicitis

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05093660
Enrollment
90
Registered
2021-10-26
Start date
2021-10-15
Completion date
2022-06-30
Last updated
2022-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Appendicitis Acute

Brief summary

Acute appendicitis is a common and potentially serious medical condition which can be difficult to diagnose, especially in pediatric patients. To help recognize patients with acute appendicitis, number of laboratory and radiological test are used. Previous research has shown that Circulating Human Leucine-rich α-2-glycoprotein (LGR1) in the blood can be elevated in pediatric patients with acute appendicitis. The aim of this research is to analyse whether LGR1 levels in saliva can be used as a less invasive diagnostic method in pediatric patients with suspected acute appendicitis.

Interventions

Blood specimen collection for analysis of CRP (C-reactive protein), WBC (White blood cells) and LRG1 (Circulating Human Leucine-rich α-2-glycoprotein) levels

DIAGNOSTIC_TESTSaliva specimen collection

Saliva specimen collection for analysis of LRG1 (Circulating Human Leucine-rich α-2-glycoprotein) levels

Sponsors

KBC Split
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
5 Years to 17 Years
Healthy volunteers
No

Inclusion criteria

* children with age from 5 do 17 with acute abdominal pain * children with clinical signs of appendicitis

Exclusion criteria

* previous diagnosis of chronic and/or malignant disease * children which had previous abdominal surgery * pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Level of LGR1 protein in blood72 hoursLevels of LGR1 protein in blood and saliva as measured by ELISA test
Level of LGR1 protein saliva72 hoursLevels of LGR1 protein in saliva as measured by ELISA test

Countries

Croatia

Contacts

Primary ContactGoran Tintor, MD
gogitintor@gmail.com+38521557111

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026